UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $42,000 | -68.4% | 2,369 | -40.6% | 0.02% | -60.9% |
| Q4 2019 | $133,000 | -62.7% | 3,987 | -73.4% | 0.05% | -65.7% |
| Q3 2019 | $357,000 | -33.8% | 15,000 | 0.0% | 0.13% | -34.0% |
| Q2 2019 | $539,000 | -2.7% | 15,000 | 0.0% | 0.20% | -15.1% |
| Q1 2019 | $554,000 | -14.2% | 15,000 | 0.0% | 0.24% | -25.5% |
| Q4 2018 | $646,000 | -8.8% | 15,000 | 0.0% | 0.32% | +10.3% |
| Q3 2018 | $708,000 | +42.2% | 15,000 | +50.0% | 0.29% | +24.9% |
| Q2 2018 | $498,000 | +122.3% | 10,000 | +122.2% | 0.23% | +113.8% |
| Q1 2018 | $224,000 | – | 4,500 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 789,297 | $39,275,000 | 60.44% |
| Wildcat Capital Management, LLC | 251,459 | $12,513,000 | 9.57% |
| Consonance Capital Management LP | 1,487,491 | $74,018,000 | 4.77% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,499,870 | $124,394,000 | 3.53% |
| MEITAV INVESTMENT HOUSE LTD | 509,355 | $29,967,000 | 1.34% |
| DSAM Partners (London) Ltd | 127,588 | $6,349,000 | 1.28% |
| SHIKIAR ASSET MANAGEMENT INC | 48,125 | $2,395,000 | 1.00% |
| BANK HAPOALIM BM | 67,125 | $3,340,000 | 0.91% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 331,900 | $16,515,000 | 0.55% |
| Clal Insurance Enterprises Holdings Ltd | 310,000 | $15,426,000 | 0.40% |